M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway
Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) said on Wednesday that it has received marketing authorisation for Bosutinib Newbury in Norway.
This marks the first step in a Scandinavian registration process, with approvals expected in Sweden and Denmark soon....
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search